eNauka - pregled
Pregled prema Projekat Takeda Pharmaceuticals International AG
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2023 | Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study | Hadden, R; Andersen, H; Bril, Vera; Basta, Ivana Z; Rejdak, Konrad; Djordjevic, Goran D; Greco, E; Hasan, S; French, J; Yel, L;
Ay, H;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2025 | Individualized Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administration in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Nurse's Role | Duff, Kim; Soresini, Arianna; Wolf, Nancy; Altan, Suekran; Bencomo, Wendy; Fairchild, Alane; Ivankovic, Ivana; Sarpong, Evelyn; Kuczkowska, Anna | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2024 | Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial | Hadden, Robert DM; Andersen, Henning; Bril, Vera; Basta, Ivana; Rejdak, Konrad; Duff, Kim; Greco, Erin; Hasan, Shabbir; Anderson, Smits Colin; Ay, Hakan | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |